Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

NCT04986657 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04986657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04986657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Recruiting
Start date
September 17, 2021
Completion date
December 31, 2027
Enrollment
325 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, myelodysplastic syndromes, whole genome sequencing